On 1 November 2018, the UK government rescheduled Cannabis-Based Medicinal Products (CBMPs) allowing specialist doctors to prescribe cannabis medicines for patients with unmet
clinical needs. We provide support for healthcare professionals to help them understand this new class of medicine as well as providing access to a wide range of CBMPs available from our exclusive global suppliers.
Cannabis thought leader, one of first UK investors into cannabis in 2016 before founding Grow Biotech in 2017. Previously spent 12 years as an Investment Banker at JPMorgan.
CEO | Grow Biotech
Operational and strategic leader with significant successes in running £50->200m businesses both in the pharmaceutical industry and services.
CCO | Grow Biotech
Former practicing pharmacist with over 40 years experience building businesses in the pharmaceutical sector. Extensive experience in all aspects of market access - unlicensed and licensed.
Co-founder | IPS Pharma
Over 30 years experience establishing international markets in the pharmaceutical sector - unlicensed and licensed - with senior roles at Intertech, Idis, Schering Plough, and Bio Products Laboratory.
CEO | IPS Pharma
Extensive background in the Pharmaceutical industry with experience working in the unlicensed and generics medicines markets.
Medical Solutions Partner | Grow Pharma
Medical Science Liaison with a background in Clinical Pharmacology. Experienced in medical affairs covering a range of therapeutic areas.
Medical Science Liaison | Grow Pharma